Cargando…
Pyridoxamine alleviates mechanical allodynia by suppressing the spinal receptor for advanced glycation end product-nuclear factor-κB/extracellular signal-regulated kinase signaling pathway in diabetic rats
Diabetic neuropathic pain is a common complication of diabetes mellitus and requires a substantial amount of societal resources. Pyridoxamine is an inhibitor of advanced glycation and lipoxidation end products. Several animal and clinical studies have confirmed that pyridoxamine can inhibit a range...
Autores principales: | Zhang, Xin, Xu, Li, Chen, Weiyun, Yu, Xuerong, Shen, Le, Huang, Yuguang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139183/ https://www.ncbi.nlm.nih.gov/pubmed/32252594 http://dx.doi.org/10.1177/1744806920917251 |
Ejemplares similares
-
Inhibitory Effect of Metformin and Pyridoxamine in the Formation of Early, Intermediate and Advanced Glycation End-Products
por: Ahmad, Saheem, et al.
Publicado: (2013) -
Advanced Glycation End Product Inhibitor Pyridoxamine Attenuates IVD Degeneration in Type 2 Diabetic Rats
por: Glaeser, Juliane D., et al.
Publicado: (2020) -
How Does Pyridoxamine Inhibit the Formation of Advanced Glycation End Products? The Role of Its Primary Antioxidant Activity
por: Ramis, Rafael, et al.
Publicado: (2019) -
Reduction of Methylglyoxal-Induced Glycation by Pyridoxamine
Improves Adipose Tissue Microvascular Lesions
por: Rodrigues, Tiago, et al.
Publicado: (2013) -
Pyridoxamine and Aminoguanidine Attenuate the Abnormal Aggregation of β-Tubulin and Suppression of Neurite Outgrowth by Glyceraldehyde-Derived Toxic Advanced Glycation End-Products
por: Ooi, Hayahide, et al.
Publicado: (2022)